Bionovis’s Acquisition of technologies to Produce Trastuzumab

Cescon, Barrieu, Flesch & Barreto and Demarest advised on the deal

Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer.

Download